Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/27/21
End: 07/24/23
Due: 07/24/24
A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia
Phase: N/A
Priority: Normal
Start: 03/29/21
End: 07/11/22
Due: 07/11/23
Phase: N/A
Priority: Normal
Start: 03/01/21
End: 08/06/24
Due: 08/06/25
Phase: N/A
Priority: Normal
Start: 10/19/21
End: 08/30/24
Due: 08/30/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia | NCT04871451 | AEON Biopharma, Inc. | user2@example.com | None | 2021-07-27 | 2023-07-24 | 2024-07-24 | - | - | 2025-07-14 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia | NCT04849988 | AEON Biopharma, Inc. | user2@example.com | None | 2021-03-29 | 2022-07-11 | 2023-07-11 | - | - | 2025-07-14 |
| Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults | NCT04845178 | AEON Biopharma, Inc. | user2@example.com | None | 2021-03-01 | 2024-08-06 | 2025-08-06 | - | - | 2025-07-14 |
| Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention | NCT05016661 | AEON Biopharma, Inc. | user2@example.com | None | 2021-10-19 | 2024-08-30 | 2025-08-30 | - | - | 2025-07-14 |